Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 13122
Publisher
Springer Nature
Online
2016-12-14
DOI
10.1038/ncomms13122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Development of a validated LC–MS/MS method for the determination of ailanthone in rat plasma with application to pharmacokinetic study
- (2015) Ang Chen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
- (2015) Joanna L Gillis et al. Oncotarget
- Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer
- (2014) Z. Yu et al. CLINICAL CANCER RESEARCH
- No clear evidence of a clinical benefit of a sequential therapy regimen with abiraterone acetate and enzalutamide
- (2014) Edoardo Francini et al. Expert Review of Anticancer Therapy
- Identification of Novel HSP90α/β Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington’s Disease
- (2014) Justin T. Ernst et al. JOURNAL OF MEDICINAL CHEMISTRY
- The co-chaperone p23 promotes prostate cancer motility and metastasis
- (2014) Laia Querol Cano et al. Molecular Oncology
- Emerging mechanisms of enzalutamide resistance in prostate cancer
- (2014) Frank Claessens et al. Nature Reviews Urology
- Targeting heat shock proteins in metastatic castration-resistant prostate cancer
- (2014) Arun A. Azad et al. Nature Reviews Urology
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-κB in Prostate Carcinoma Cells
- (2014) Kun-Chun Chiang et al. PLoS One
- Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity
- (2013) Min Sun et al. FITOTERAPIA
- Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis
- (2013) Chaitanya A. Patwardhan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mini-review: Foldosome regulation of androgen receptor action in prostate cancer
- (2013) Laia Querol Cano et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
- (2013) X Yuan et al. ONCOGENE
- Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-κB Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer
- (2013) Longjiang Shao et al. PLoS One
- Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression
- (2013) Ayesha A. Shafi et al. STEROIDS
- The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
- (2012) Naomi L. Sharma et al. CANCER CELL
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal
- (2012) Siu Chiu Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer
- (2012) Vikash Reebye et al. MOLECULAR ENDOCRINOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
- (2011) Elahe A. Mostaghel et al. CLINICAL CANCER RESEARCH
- Molecular chaperones in protein folding and proteostasis
- (2011) F. Ulrich Hartl et al. NATURE
- Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells
- (2011) J. T. De Leon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen receptor signaling and mutations in prostate cancer
- (2010) Shahriar Koochekpour ASIAN JOURNAL OF ANDROLOGY
- High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance
- (2010) N. E. Simpson et al. CANCER RESEARCH
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
- (2010) Shihua Sun et al. JOURNAL OF CLINICAL INVESTIGATION
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice
- (2009) C.-H. Tsai et al. CLINICAL CANCER RESEARCH
- Update on Hsp90 Inhibitors in Clinical Trial
- (2009) Y. Kim et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Molecular mechanisms of castration-resistant prostate cancer progression
- (2009) Smitha S Dutt et al. Future Oncology
- Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity
- (2009) Junjiang Fu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23
- (2009) Ahmed Chadli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
- (2009) A. Gibbs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- p23/Sba1p Protects against Hsp90 Inhibitors Independently of Its Intrinsic Chaperone Activity
- (2008) F. Forafonov et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now